PROGENICS PHARMACEUTICALS INC 4
4 · PROGENICS PHARMACEUTICALS INC · Filed Mar 3, 2016
Insider Transaction Report
Form 4
Baker Mark Robert
General Counsel
Transactions
- Award
Non-Qualified Stock Option (right to buy)
2016-03-01$4.52/sh+175,000$791,000→ 175,000 totalExercise: $4.52Exp: 2026-03-01→ Common Stock (175,000 underlying)
Footnotes (1)
- [F1]The stock options become exercisable in three equal annual installments, commencing one year from the grant date.